Calypso Medical

company

About

Calypso Medical develops tumor localization systems designed to accurately and objectively track the location of tumors in human bodies.

  • 5001 - 10000

Details

Last Funding Type
Series D
Last Funding Money Raised
$42.20M
Industries
Health Care,Medical,Medical Device
Founded date
Oct 1, 1999
Number Of Employee
5001 - 10000
Operating Status
Active

Calypso Medical Technologies is a Seattle-based, privately held medical device company. The Company's proprietary tumor localization system utilizes miniaturized implanted devices (Beacon® electromagnetic transponders) to continuously, accurately and objectively track the location of tumors for improved accuracy and management of radiation therapy delivery. The technology is designed for body-wide cancers commonly treated with radiation therapy. The products are FDA 510(k) cleared for use in the prostate and post-operative prostatic bed. The Company has strategic relationships with Varian Medical Systems, Siemens Medical Systems, Elekta Corporation, and Philips Medical.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$49.04M
Calypso Medical has raised a total of $49.04M in funding over 2 rounds. Their latest funding was raised on Jan 8, 2007 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 8, 2007 Series D $42.20M 2 Apothecary Capital Detail
Jan 7, 2005 Series C $6.84M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Calypso Medical is funded by 2 investors. Apothecary Capital and Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Apothecary Capital Yes Series D
Versant Ventures Series D